Disseminated and circulating tumor cells in gastrointestinal oncology;Cellules tumorales circulantes et disséminées en oncologie digestive

Bulletin du Cancer

Volumn 99, Issue 5, 2012, Pages 535-544

  Vegas, Hél̀ene ^a   André, Thierry ^b   Bidard, François Cĺement ^a   Ferrand, François Ŕegis ^c   Huguet, Florence ^d   Mariani, Pascale ^a   Pierga, Jean Yves ^a  

^a INSTITUT CURIE   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c University of Paris Descartes   (France)

^d HÔPITAL TENON   (France)

Author keywords

Biomarker; Circulating tumor cells; Digestive cancer; Disseminated tumor cells; Micrometastases

Indexed keywords

BIOLOGICAL MARKER; MOLECULAR MARKER;

BLOOD; CANCER DIAGNOSIS; CANCER STAGING; CIRCULATING TUMOR CELL; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; CYTOLOGY; DIGESTIVE SYSTEM CANCER; DISEASE FREE SURVIVAL; HUMAN; METASTASIS; OVERALL SURVIVAL; REVIEW; TUMOR LOCALIZATION;

EID: 84861445795     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2012.1581     Document Type: Article

References (70)

1. Bidard FC, Saliba AE, Saias L, et al. Circulating tumor cells and breast cancer: detection techniques and clinical results. Bull Cancer 2009; 96 : 73-86.
2. Rahbari NN, Aigner M, Thorlund K, et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 2010; 138 : 1714-26.
3. Chechlinska M, Kowalewska M, Nowak R. Systemic inflammation as a confounding factor in cancer biomarker discovery and validation. Nat Rev Cancer 2010; 10 : 2-3.
4. Allard WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004; 10 : 6897-904. (Pubitemid 39383039)
5. Thorban S, Roder JD, Nekarda H, Funk A, Siewert JR, Pantel K. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma. J Natl Cancer Inst 1996; 88 : 1222-7. (Pubitemid 26302036)
6. Stoecklein NH, Hosch SB, Bezler M, et al. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell 2008; 13 : 441-53. (Pubitemid 351609446)
7. Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009; 9 : 302-12.
8. Nakashima S, Natsugoe S, Matsumoto M, et al. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer. Surgery 2003; 133 : 162-9. (Pubitemid 36407980)
9. Liu Z, Jiang M, Zhao J, Ju H. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility. Clin Cancer Res 2007; 13 : 2992-7. (Pubitemid 46849575)
10. Cao M, Yie SM, Wu SM, et al. Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance. Clin Exp Metastasis 2009; 26 : 751-8.
11. Hoffmann AC, Vallbohmer D, Grimminger P, et al. Preoperative survivin mRNA detection in peripheral blood is an independent predictor of outcome in esophageal carcinoma. Pharmacogenomics 2010; 11 : 341-7.
12. Hiraiwa K, Takeuchi H, Hasegawa H, et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol 2008; 15 : 3092-100.
13. Buergy D, Fuchs T, Kambakamba P, et al. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer. Cancer 2009; 115 : 4667-78.
14. Miyazono F, Natsugoe S, Takao S, et al. Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery. Ann Surg 2001; 233 : 189-94. (Pubitemid 32106072)
15. Ikeguchi M, Kaibara N. Detection of circulating cancer cells after a gastrectomy for gastric cancer. Surg Today 2005; 35 : 436-41. (Pubitemid 40873804)
16. Kolodziejczyk P, Pituch-Noworolska A, Drabik G, et al. The effects of preoperative chemotherapy on isolated tumour cells in the blood and bone marrow of gastric cancer patients. Br J Cancer 2007; 97 : 589-92. (Pubitemid 47339883)
17. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438 : 820-7. (Pubitemid 41753060)
18. Matsusaka S, Chin K, Ogura M, et al. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer. Cancer Sci 2010; 101 : 1067-71.
19. Ko AH, Scott J, Tempero MA, Park JW. Detection and significance of circulating tumor cells (CTC) in patients with metastatic pancreatic cancer (PC) receiving systemic therapy. J Clin Oncol 2007; 25(18s), abstract 4596.
20. Kurihara T, Itoi T, Sofuni A, et al. Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result. J Hepatobiliary Pancreat Surg 2008; 15 : 189-95. (Pubitemid 351516978)
21. Negin BP, Meropol NJ, Alpaugh RK, et al. Characterization and prognostic significance of circulating tumor cells in the peripheral blood of patients with metastatic pancreatic cancer. J Clin Oncol 2010 ; 28(15s), abstr 4127.
22. Z'Graggen K, Centeno BA, Fernandez del Castillo C, Jimenez RE, Werner J, Warshaw AL. Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients. Surgery 2001; 129 : 537-46.
23. Nagrath S, Sequist LV, Maheswaran S, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007; 450 : 1235-9.
24. Thorban S, Roder JD, Siewert JR. Detection of micrometastasis in bone marrow of pancreatic cancer patients. Ann Oncol 1999; 10(Suppl. 4) : 111-3.
25. Khan MS, Tsigani T, Rashid M, et al. Circulating tumor cells and EpCAM expression in neuroendocrine tumors. Clin Cancer Res 2011; 17 : 337-45.
26. Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmüller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992; 340 : 685-9.
27. Sales JP, Wind P, Douard R, Cugnenc PH, Loric S. Blood dissemination of colonic epithelial cells during no-touch surgery for rectosigmoid cancer [letter]. Lancet 1999; 354 : 392. (Pubitemid 29355759)
28. Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000; 232 : 58-65. (Pubitemid 30456551)
29. Maruthachalam K, Lash GE, Shenton BK, Horgan AF. Tumour cell dissemination following endoscopic stent insertion. Br J Surg 2007; 94 : 1151-4. (Pubitemid 350082863)
30. Katsuno H, Zacharakis E, Aziz O, et al. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis. Ann Surg Oncol 2008; 15 : 3083-91.
31. Uen YH, Lin SR, Wu DC, et al. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Ann Surg 2007; 246 : 1040-6.
32. Iinuma H, Watanabe T, Mimori K, et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J Clin Oncol 2011; 29 : 1547-55.
33. Vlems FA, Diepstra JH, Punt CJ, et al. Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer. Br J Surg 2003; 90 : 989-95. (Pubitemid 37026329)
34. Vogelaar FJ, Mesker WE, Rijken AM, et al. Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study. BMC Cancer 2010; 10 : 153.
35. Bidard FC, Vincent-Salomon A, Sigal-Zafrani B, et al. Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells. Ann Oncol 2008; 19 : 496-500. (Pubitemid 351325670)
36. Uchikura K, Takao S, Nakajo A, et al. Intraoperative molecular detection of circulating tumor cells by reverse transcriptionpolymerase chain reaction in patients with biliary-pancreatic cancer is associated with hematogenous metastasis. Ann Surg Oncol 2002; 9 : 364-70. (Pubitemid 34496724)
37. Jiao LR, Apostolopoulos C, Jacob J, et al. Unique localization of circulating tumor cells in patients with hepatic metastases. J Clin Oncol 2009; 27 : 6160-5.
38. Schmidt T, Koch M, Antolovic D, et al. Influence of two different resection techniques (conventional liver resection versus anterior approach) of liver metastases from colorectal cancer on hematogenous tumor cell dissemination - prospective randomized multicenter trial. BMC Surg 2008; 8 : 6.
39. Cohen SJ, Punt CJ, Iannotti N, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008; 26 : 3213-21.
40. Tol J, Koopman M, Miller MC, et al. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann Oncol 2010; 21 : 1006-12.
41. Matsumura M, Niwa Y, Kato N, et al. Detection of alphafetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994; 20 : 1418-25. (Pubitemid 24359050)
42. Kienle P,Weitz J, Klaes R, et al. Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma. Arch Surg 2000; 135 : 213-8. (Pubitemid 30078479)
43. Aselmann H, Wolfes H, Rohde F, et al. Quantification of alpha 1-fetoprotein mRNA in peripheral blood and bone marrow: a tool for perioperative evaluation of patients with hepatocellular carcinoma. Langenbecks Arch Surg 2001; 386 : 118-23.
44. Vona G, Sabile A, Louha M, et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol 2000; 156 : 57-63. (Pubitemid 30644439)
45. Zee BC, Wong BC, Kuhn T, et al. Detection of circulating tumor cells (CTCs) in patients with hepatocellular carcinoma (HCC). J Clin Oncol 2007; 25 : 15037.
46. Obayashi T, Taniguchi H, Mugitani T, et al. Safety and utility of autologous blood transfusion for resection of metastatic liver tumor. Hepatogastroenterology 2001; 48 : 812-7. (Pubitemid 32619687)
47. Sumikura S, Ishigami S, Natsugoe S, et al. Disseminated cancer cells in the blood and expression of sialylated antigen in gastric cancer. Cancer Lett 2003; 200 : 77-83. (Pubitemid 37222361)
48. Seo JH, Choi CW, Kim BS, et al. Follow-up study of peripheral blood carcinoembryonic antigen mRNA using reverse transcriptionpolymerase chain reaction as an early marker of clinical recurrence in patients with curatively resected gastric cancer. Am J Clin Oncol 2005; 28 : 24-9.
49. Illert B, Fein M, Otto C, et al. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis. Scand J Gastroenterol 2005; 40 : 843-9. (Pubitemid 40978861)
50. Uen YH, Lin SR, Wu CH, et al. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma. Clin Chim Acta 2006; 367 : 55-61.
51. Wu CH, Lin SR, Yu FJ, et al. Development of a high-throughput membrane-array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers. Int J Cancer 2006; 119 : 373-9.
52. Koga T, Tokunaga E, Sumiyoshi Y, et al. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Hepatogastroenterology 2008; 55 : 1131-5. (Pubitemid 351976002)
53. Yie SM, Lou B, Ye SR, et al. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Ann Surg Oncol 2008; 15 : 3073-82.
54. Saad AA, Awed NM, Abd Elkerim NN, et al. Prognostic significance of E-cadherin expression and peripheral blood micrometastasis in gastric carcinoma patients. Ann Surg Oncol 2010; 17 : 3059-67.
55. Cohen SJ, Alpaugh RK, Gross S, et al. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer 2006; 6 : 125-32. (Pubitemid 44445747)
56. Sastre J, Maestro ML, Puente J, et al. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 2008; 19 : 935-8. (Pubitemid 351627310)
57. Maestro LM, Sastre J, Rafael SB, et al. Circulating tumor cells in solid tumor in metastatic and localized stages. Anticancer Res 2009; 29 : 4839-43.
58. Cohen SJ, Punt CJ, Iannotti N, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 2009; 20 : 1223-9.
59. Papavasiliou P, Fisher T, Kuhn J, et al. Circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Proc (Bayl Univ Med Cent) 2010; 23 : 11-4.
60. Louha M, Poussin K, Ganne N, et al. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology 1997; 26 : 998-1005. (Pubitemid 27413670)
61. Matsumura M, Shiratori Y, Niwa Y, et al. Presence of alphafetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma. J Hepatol 1999; 31 : 332-9. (Pubitemid 29349761)
62. Wong IH, Lau WY, Leung T, et al. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res 1999; 5 : 4021-7. (Pubitemid 30013779)
63. Wong IH, Lau WY, Leung T, et al. Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/ adenoma, non-tumor liver and blood: implications in cancer detection and monitoring. Cancer Lett 2000; 156 : 141-9. (Pubitemid 30394671)
64. Miyamoto A, Nagano H, Sakon M, et al. Clinical application of quantitative analysis for detection of hematogenous spread of hepatocellular carcinoma by real-time PCR. Int J Oncol 2001; 18 : 527-32.
65. Witzigmann H, Geissler F, Benedix F, et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery 2002; 131 : 34-43. (Pubitemid 34118594)
66. Gross-Goupil M, Saffroy R, Azoulay D, et al. Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma. Ann Surg 2003; 238 : 241-8. (Pubitemid 38174499)
67. Cillo U, Navaglia F, Vitale A, et al. Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma. Clin Chim Acta 2004; 347 : 129-38. (Pubitemid 39099614)
68. Jeng KS, Sheen IS, Tsai YC. Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma. Arch Surg 2004; 139 : 1055-60.
69. Jeng KS, Sheen IS, Tsai YC. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection? Am J Gastroenterol 2004; 99 : 1503-9.
70. Morimoto O, Nagano H, Miyamoto A, et al. Association between recurrence of hepatocellular carcinoma and alphafetoprotein messenger RNA levels in peripheral blood. Surg Today 2005; 35 : 1033-41. (Pubitemid 41772299)